UBS Group’s Churchill Capital Corp VII Warrants CVIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-351
Closed -$123 – 10399
2024
Q2
$123 Buy
+351
New +$93 ﹤0.01% 9134
2024
Q1
– Sell
-3,760
Closed -$602 – 10243
2023
Q4
$602 Buy
+3,760
New +$625 ﹤0.01% 8576
2023
Q2
– Sell
-17,488
Closed -$2.13K – 9931
2023
Q1
$2.13K Sell
17,488
-1,222
-7% -$104 ﹤0.01% 8571
2022
Q4
$936 Buy
18,710
+6,756
+57% +$291 ﹤0.01% 10026
2022
Q3
$2K Sell
11,954
-481
-4% -$108 ﹤0.01% 9817
2022
Q2
$4K Buy
+12,435
New +$5.38K ﹤0.01% 9173
2022
Q1
– Sell
-6,433
Closed -$6K – 11101
2021
Q4
$6K Buy
6,433
+5,358
+498% +$5.83K ﹤0.01% 9309
2021
Q3
$1K Buy
+1,075
New +$1.2K ﹤0.01% 9283

UBS Group's CVIIW Position: Q3 2024 in Review

UBS Group sold out of Churchill Capital Corp VII Warrants (CVIIW) in Q3 2024, closing a stake of 351 shares — an estimated $123 sold.

UBS Group first reported a position in CVIIW in Q3 2021 and held it in 8 quarters. The position peaked at $6K in Q4 2021. 0 funds tracked by Wall St. Rank hold CVIIW as of Q3 2024.

  • UBS Group reported no remaining Churchill Capital Corp VII Warrants position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 351 Churchill Capital Corp VII Warrants shares in Q3 2024, an estimated $123.
  • UBS Group first reported a position in Churchill Capital Corp VII Warrants in Q3 2021 and held it in 8 quarters.
  • UBS Group's Churchill Capital Corp VII Warrants position peaked at $6K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Churchill Capital Corp VII Warrants as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.